Cormorant Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-450,000	Closed	-$20.8M	–	74
2019 Q2	$20.8M	Sell	450,000 -50,000	-10%	-$2.32M	1.2%	26
2019 Q1	$12.2M	Sell	500,000 -80,756	-14%	-$1.97M	0.82%	36
2018 Q4	$8.28M	Sell	580,756 -19,244	-3%	-$274K	0.67%	35
2018 Q3	$9.12M	Sell	600,000 -68,743	-10%	-$1.04M	0.59%	33
2018 Q2	$11.2M	Hold	668,743	–	–	0.83%	35
2018 Q1	$10.9M	Sell	668,743 -31,257	-4%	-$510K	0.81%	24
2017 Q4	$8.96M	Sell	700,000 -200,000	-22%	-$2.56M	0.94%	25
2017 Q3	$11.1M	Hold	900,000	–	–	1.95%	17
2017 Q2	$7.53M	Hold	900,000	–	–	1.25%	25
2017 Q1	$8.05M	Sell	900,000 -250,000	-22%	-$2.24M	1.17%	31
2016 Q4	$10.1M	Hold	1,150,000	–	–	1.36%	23
2016 Q3	$7.76M	Buy	+1,150,000	New	+$7.76M	0.86%	40
2015 Q4	–	Sell	-850,000	Closed	-$3.88M	–	94
2015 Q3	$3.88M	Hold	850,000	–	–	0.62%	44
2015 Q2	$6.13M	Hold	850,000	–	–	0.81%	37
2015 Q1	$6.27M	Sell	850,000 -150,000	-15%	-$1.11M	0.97%	34
2014 Q4	$4.73M	Hold	1,000,000	–	–	0.73%	36
2014 Q3	$3.57M	Hold	1,000,000	–	–	0.73%	37
2014 Q2	$4.56M	Sell	1,000,000 -750,000	-43%	-$3.42M	1.21%	31
2014 Q1	$8.23M	Hold	1,750,000	–	–	1.89%	24
2013 Q4	$8.77M	Buy	+1,750,000	New	+$8.77M	2.54%	15